-
1
-
-
77952355761
-
Prophylaxis of cervical cancer and related cervical disease: A review of the cost-effectiveness of vaccination against oncogenic HPV types
-
Armstrong EP: Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Manag Care Pharm 16: 217-230, 2010.
-
(2010)
J Manag Care Pharm
, vol.16
, pp. 217-230
-
-
Armstrong, E.P.1
-
2
-
-
79952857310
-
-
IARC. Accessed September 20, 2013
-
Globocan 2008, IARC. http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900#WOMEN. Accessed September 20, 2013.
-
Globocan 2008
-
-
-
4
-
-
84874877369
-
Role of Pap smear in early diagnosis of cervical cancer-A case study of women in Saudi Arabia
-
Haroon S and Cui M: Role of Pap smear in early diagnosis of cervical cancer-A case study of women in Saudi Arabia. Life Science Journal 9: 1027-1036, 2012.
-
(2012)
Life Science Journal
, vol.9
, pp. 1027-1036
-
-
Haroon, S.1
Cui, M.2
-
5
-
-
33745077013
-
Suppression of human cervical cancer cell lines Hela and DoTc2 4510 by a mixture of lysine, proline, ascorbic acid, and green tea extract
-
Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A and Rath M: Suppression of human cervical cancer cell lines Hela and DoTc2 4510 by a mixture of lysine, proline, ascorbic acid, and green tea extract. Int J Gynecol Cancer 16: 1241-1247, 2006.
-
(2006)
Int J Gynecol Cancer
, vol.16
, pp. 1241-1247
-
-
Roomi, M.W.1
Ivanov, V.2
Kalinovsky, T.3
Niedzwiecki, A.4
Rath, M.5
-
6
-
-
33947726393
-
Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines
-
Faried A, Kurnia D, Faried LS, et al: Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int J Oncol 30: 605-613, 2007.
-
(2007)
Int J Oncol
, vol.30
, pp. 605-613
-
-
Faried, A.1
Kurnia, D.2
Faried, L.S.3
-
7
-
-
49849088399
-
Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice
-
Raina K, Rajamanickam S, Deep G, Singh M, Agarwal R and Agarwal C: Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice. Mol Cancer Ther 7: 1258-1267, 2008.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 1258-1267
-
-
Raina, K.1
Rajamanickam, S.2
Deep, G.3
Singh, M.4
Agarwal, R.5
Agarwal, C.6
-
8
-
-
77953613901
-
Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase
-
You BR and Park WH: Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase. Toxicol In Vitro 24: 1356-1362, 2010.
-
(2010)
Toxicol In Vitro
, vol.24
, pp. 1356-1362
-
-
You, B.R.1
Park, W.H.2
-
9
-
-
84870412005
-
Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion
-
You BR, Kim SZ, Kim SH and Park WH: Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion. Mol Cell Biochem 357: 295-303, 2011.
-
(2011)
Mol Cell Biochem
, vol.357
, pp. 295-303
-
-
You, B.R.1
Kim, S.Z.2
Kim, S.H.3
Park, W.H.4
-
11
-
-
77951622906
-
Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis
-
You BR, Moon HJ, Han YH and Park WH: Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis. Food Chem Toxicol 48: 1334-1340, 2010.
-
(2010)
Food Chem Toxicol
, vol.48
, pp. 1334-1340
-
-
You, B.R.1
Moon, H.J.2
Han, Y.H.3
Park, W.H.4
-
12
-
-
0025341331
-
New colorimetric cytotoxicity assay for anticancer-drug screening
-
Skehan P, Storeng R, Scudiero D, et al: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112, 1990.
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 1107-1112
-
-
Skehan, P.1
Storeng, R.2
Scudiero, D.3
-
13
-
-
33846243771
-
Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells
-
Agarwal C, Tyagi A and Agarwal R: Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells. Mol Cancer Ther 5: 3294-3302, 2006.
-
(2006)
Mol Cancer Ther
, vol.5
, pp. 3294-3302
-
-
Agarwal, C.1
Tyagi, A.2
Agarwal, R.3
-
14
-
-
77957261402
-
Loss of estrogen receptor 1 enhances cervical cancer invasion
-
Zhai Y, Bommer GT, Feng Y, Wiese AB, Fearon ER and Cho KR: Loss of estrogen receptor 1 enhances cervical cancer invasion. Am J Pathol 177: 884-895, 2010.
-
(2010)
Am J Pathol
, vol.177
, pp. 884-895
-
-
Zhai, Y.1
Bommer, G.T.2
Feng, Y.3
Wiese, A.B.4
Fearon, E.R.5
Cho, K.R.6
-
15
-
-
0031938111
-
Angiogenesis as a prognostic factor in cervical carcinoma
-
Di Leo S, Caschetto S, Garozzo G, et al: Angiogenesis as a prognostic factor in cervical carcinoma. Eur J Gynaecol Oncol 19: 158-162, 1998.
-
(1998)
Eur J Gynaecol Oncol
, vol.19
, pp. 158-162
-
-
Di Leo, S.1
Caschetto, S.2
Garozzo, G.3
-
16
-
-
33646034061
-
Angiogenesis in cervical intraepithelial neoplasia and early-staged uterine cervical squamous cell carcinoma: Clinical significance
-
Triratanachat S, Niruthisard S, Trivijitsilp P, Tresukosol D and Jarurak N: Angiogenesis in cervical intraepithelial neoplasia and early-staged uterine cervical squamous cell carcinoma: clinical significance. Int J Gynecol Cancer 16: 575-580, 2006.
-
(2006)
Int J Gynecol Cancer
, vol.16
, pp. 575-580
-
-
Triratanachat, S.1
Niruthisard, S.2
Trivijitsilp, P.3
Tresukosol, D.4
Jarurak, N.5
-
17
-
-
83555174918
-
ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway
-
Lin P, Sun X, Feng T, et al: ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway. Mol Cell Biochem 359: 235-243, 2012.
-
(2012)
Mol Cell Biochem
, vol.359
, pp. 235-243
-
-
Lin, P.1
Sun, X.2
Feng, T.3
-
18
-
-
84860289206
-
ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion
-
Xiao LJ, Lin P, Lin F, et al: ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion. Int J Oncol 40: 1714-1724, 2012.
-
(2012)
Int J Oncol
, vol.40
, pp. 1714-1724
-
-
Xiao, L.J.1
Lin, P.2
Lin, F.3
-
19
-
-
84863115594
-
Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells
-
Jeong JH, Jeong YJ, Cho HJ, et al: Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells. J Cell Biochem 113: 1302-1313, 2012.
-
(2012)
J Cell Biochem
, vol.113
, pp. 1302-1313
-
-
Jeong, J.H.1
Jeong, Y.J.2
Cho, H.J.3
-
20
-
-
0033668390
-
Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer
-
Mathur SP, Mathur RS and Young RC: Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer. Am J Reprod Immunol 44: 222-230, 2000.
-
(2000)
Am J Reprod Immunol
, vol.44
, pp. 222-230
-
-
Mathur, S.P.1
Mathur, R.S.2
Young, R.C.3
-
21
-
-
0030747669
-
Epidermal growth factor and its receptor in cervical cancer
-
Lakshmi S, Nair M, Jayaprakash P and Pillai M: Epidermal growth factor and its receptor in cervical cancer. Oncol Rep 4: 1103-1106, 1997.
-
(1997)
Oncol Rep
, vol.4
, pp. 1103-1106
-
-
Lakshmi, S.1
Nair, M.2
Jayaprakash, P.3
Pillai, M.4
-
22
-
-
0038386695
-
Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy
-
Gaffney DK, Haslam D, Tsodikov A, et al: Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys 56: 922-928, 2003.
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.56
, pp. 922-928
-
-
Gaffney, D.K.1
Haslam, D.2
Tsodikov, A.3
-
23
-
-
33845606670
-
Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells
-
Madlener S, Illmer C, Horvath Z, et al: Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. Cancer Lett 245: 156-162, 2007.
-
(2007)
Cancer Lett
, vol.245
, pp. 156-162
-
-
Madlener, S.1
Illmer, C.2
Horvath, Z.3
-
24
-
-
0030784939
-
Angiogenesis of uterine cervical carcinoma: Characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement
-
Hawighorst H, Knapstein PG, Weikel W, et al: Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 57: 4777-4786, 1997.
-
(1997)
Cancer Res
, vol.57
, pp. 4777-4786
-
-
Hawighorst, H.1
Knapstein, P.G.2
Weikel, W.3
-
25
-
-
33748785156
-
Gallic acid is partially responsible for the antiangiogenic activities of Rubus leaf extract
-
Liu Z, Schwimer J, Liu D, et al: Gallic acid is partially responsible for the antiangiogenic activities of Rubus leaf extract. Phytother Res 20: 806-813, 2006.
-
(2006)
Phytother Res
, vol.20
, pp. 806-813
-
-
Liu, Z.1
Schwimer, J.2
Liu, D.3
-
26
-
-
80053148870
-
Epidermal growth factor receptor as a biomarker for cervical cancer
-
Soonthornthum T, Arias-Pulido H, Joste N, et al: Epidermal growth factor receptor as a biomarker for cervical cancer. Ann Oncol 22: 2166-2178, 2011.
-
(2011)
Ann Oncol
, vol.22
, pp. 2166-2178
-
-
Soonthornthum, T.1
Arias-Pulido, H.2
Joste, N.3
-
27
-
-
0036362181
-
Why the epidermal growth factor receptor? The rationale for cancer therapy
-
Baselga J: Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 7 (Suppl 4): 2-8, 2002.
-
(2002)
Oncologist
, vol.7
, Issue.SUPPL. 4
, pp. 2-8
-
-
Baselga, J.1
-
29
-
-
0036007414
-
Shedding light on sheddases: Role in growth and development
-
Kheradmand F and Werb Z: Shedding light on sheddases: role in growth and development. Bioessays 24: 8-12, 2002.
-
(2002)
Bioessays
, vol.24
, pp. 8-12
-
-
Kheradmand, F.1
Werb, Z.2
-
30
-
-
67649095267
-
ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation
-
Zheng X, Jiang F, Katakowski M, Zhang ZG, Lu QE and Chopp M: ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation. Cancer Biol Ther 8: 1045-1054, 2009.
-
(2009)
Cancer Biol Ther
, vol.8
, pp. 1045-1054
-
-
Zheng, X.1
Jiang, F.2
Katakowski, M.3
Zhang, Z.G.4
Lu, Q.E.5
Chopp, M.6
|